New treatment tested for kids with severe Crohn's disease
NCT ID NCT01580670
Summary
This study tested a medication called TA-650 in children with moderate to severe Crohn's disease. The goal was to see if regular injections could reduce disease activity and control symptoms. Researchers measured changes in a disease activity score and monitored safety in 14 pediatric patients in Japan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Chūbu, Japan
-
Investigational site
Hokkaido, Japan
-
Investigational site
Hokuriku, Japan
-
Investigational site
Kanto, Japan
-
Investigational site
Kinki, Japan
-
Investigational site
Kyusyu, Japan
-
Investigational site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.